Fluoxetine: A treatment option for severe symptomatic postural hypotension in a diabetic haemodialysis patient [1]

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 5, 1996, Pages 714-

  Chin, C K ^b   Roe, C J ^b   Thomas, G W ^a  

^a AUSTIN HEALTH   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; FLUDROCORTISONE; FLUOXETINE; MINOXIDIL; PRAZOSIN;

ADULT; CASE REPORT; DIABETIC NEUROPATHY; DRUG CHOICE; DRUG EFFICACY; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; LETTER; MALE; ORTHOSTATIC HYPOTENSION;

EID: 0029904825     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb02948.x     Document Type: Letter

References (6)

1. Grubb BP, Samoil D, Kosinski D, Wolfe D, Lorton M, Madu E. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am J Med 1994; 97: 366-8.
2. Grubb BP, Wolfe D, Samoil D et al. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. PACE 1993; 16: 458-64.
3. Rickels K, Schweizer E. Clinical overview of serotonin uptake inhibitors. J Clin Psychiatry 1990; 51 (Suppl): 9-12.
4. Abbound FM. Neurocardiogenic syncope. N Engl J Med 1993; 328: 1117-9.
5. Schadt TC, Ludbrook J. Haemodynamic and neurohumeral responses to acute hypovolaemia in conscious mammals. Am J Physiol (Heart Circ Physiol 29) 1991; 260: H305-H318.
6. Elam RF, Bergmann F, Feuerstein G. The use of anti-serotonergic agents for treatment of acute haemorrhagic shock in cats. Eur J Pharmacol 1985; 107: 275-8.